A Comparison of Two Sedation Techniques in Children Undergoing Transthoracic Echocardiography (TTE)

NCT02250820 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2020-01-21

No results posted yet for this study

Summary

The study will examine the quality of two sedation techniques (dexmedetomidine and pentobarbital) used for children aged 3 to 24 months who are undergoing a transthoracic echocardiography (TTE).

Conditions

Interventions

DRUG

Dexmedetomidine

Nasal administration

DRUG

Pentobarbital

Oral administration

OTHER

Oral Placebo

Oral placebo will be cherry syrup

OTHER

Nasal Placebo

Nasal placebo will be nasally atomized saline

Sponsors & Collaborators

  • Children's Hospital Medical Center, Cincinnati

    lead OTHER

Principal Investigators

  • Jeff Miller, MD · Children's Hospital Medical Center, Cincinnati

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
3 Months
Max Age
24 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02250820 on ClinicalTrials.gov